Advertisement
Research Article

Comparison of Xpert MTB/RIF with Other Nucleic Acid Technologies for Diagnosing Pulmonary Tuberculosis in a High HIV Prevalence Setting: A Prospective Study

  • Lesley E. Scott mail,

    lesley.scott@nhls.ac.za

    Affiliation: Department of Molecular Medicine and Hematology, University of the Witwatersrand, Johannesburg, South Africa

    X
  • Kerrigan McCarthy,

    Affiliation: Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa

    X
  • Natasha Gous,

    Affiliation: Department of Molecular Medicine and Hematology, University of the Witwatersrand, Johannesburg, South Africa

    X
  • Matilda Nduna,

    Affiliation: National Health Laboratory Service, Johannesburg, South Africa

    X
  • Annelies Van Rie,

    Affiliation: Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

    X
  • Ian Sanne,

    Affiliation: Clinical HIV Research Unit, Department of Medicine, University of the Witwatersrand, and Right to Care, Johannesburg, South Africa

    X
  • Willem F. Venter,

    Affiliation: Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa

    X
  • Adrian Duse,

    Affiliations: National Health Laboratory Service, Johannesburg, South Africa, Department of Clinical Microbiology and Infectious Diseases, University of the Witwatersrand, Johannesburg, South Africa

    X
  • Wendy Stevens

    Affiliations: Department of Molecular Medicine and Hematology, University of the Witwatersrand, Johannesburg, South Africa, National Health Laboratory Service, Johannesburg, South Africa

    X
  • Published: July 26, 2011
  • DOI: 10.1371/journal.pmed.1001061

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis

David W. Dowdy, Adithya Cattamanchi, Karen R. Steingart, Madhukar Pai
Essay | published 26 Jul 2011 | PLOS Medicine
doi:10.1371/journal.pmed.1001063

GeneXpert—A Game-Changer for Tuberculosis Control?

Carlton A. Evans
Perspective | published 26 Jul 2011 | PLOS Medicine
doi:10.1371/journal.pmed.1001064

Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study

Stephen D. Lawn, Sophie V. Brooks, Katharina Kranzer, Mark P. Nicol, Andrew Whitelaw, Monica Vogt, Linda-Gail Bekker, Robin Wood
Research Article | published 26 Jul 2011 | PLOS Medicine
doi:10.1371/journal.pmed.1001067